SML1619-25MG Display Image

TAZAROTENIC ACID

Code: SML1619-25MG D2-231

Biochem/physiol Actions

Tazarotene is transformed to tazarotenic acid with the help of esterases. Tazarotenic acid regulates the pathogenic aspects of psoriasis through norma...


read more

Your Price
£556.00 25MG
£667.20 inc. VAT

Biochem/physiol Actions

Tazarotene is transformed to tazarotenic acid with the help of esterases. Tazarotenic acid regulates the pathogenic aspects of psoriasis through normalizing abnormal keratinocyte differentiation. It possesses strong anti-hyperproliferative effects in skin and reduces inflammation.

Tazarotenic acid, an active metabolite of tazarotene, is a potent and selective agonist of the retinoid receptor (RAR) that binds to RARα, RARβ, and RARγ. Tazarotenic acid relatively selective activates RARβ and RARγ. Tazarotenic acid is a first xenobiotic substrate of human retinoic acid hydroxylase CYP26A1 and CYP26B1.

Packaging

5, 25 mg in glass bottle

assay≥98% (HPLC)
colorwhite to light brown
formpowder
InChI keyIQIBKLWBVJPOQO-UHFFFAOYSA-N
InChI1S/C19H17NO2S/c1-19(2)9-10-23-17-8-4-13(11-16(17)19)3-6-15-7-5-14(12-20-15)18(21)22/h4-5,7-8,11-12H,9-10H2,1-2H3,(H,21,22)
Quality Level100
SMILES stringCC1(C)CCSC2=C1C=C(C#CC3=CC=C(C(O)=O)C=N3)C=C2
solubilityDMSO: 20 mg/mL, clear
storage temp.2-8°C
Code
Description
Unit Size
List Price
Qty
SML1619-5MG
Unit:5MG
List Price: £139.00
Source:List Price
ADD
Cas Number118292-41-4
This product has met the following criteria: